InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-23.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Fratamico Arthur, Director. Insider active across 1 company, notably Panbela Therapeutics, Inc.. Cumulatively, 2 disclosures have been recorded. Activity tracked since 25 May 2021. The latest transaction was filed on 25 May 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
4,316 shares0Common StockSEC:0001437749-21-013595:0
4,316 shares0Common StockSEC:0001437749-21-013595
2 of 2 declarations
About Fratamico Arthur
Arthur Fratamico is a Director at Panbela Therapeutics, Inc. He plays a vital role in the governance of the company, bringing his expertise in biotechnology and pharmaceutical development. As a board member, Arthur participates in strategic decision-making that influences the company's performance and direction. His experience in the sector enables him to contribute to discussions on innovation and the development of new treatments, thereby strengthening the company's market position.
